Structure

Physi-Chem Properties

Molecular Weight:  798.27
Volume:  778.693
LogP:  5.683
LogD:  2.741
LogS:  -3.425
# Rotatable Bonds:  0
TPSA:  273.11
# H-Bond Aceptor:  17
# H-Bond Donor:  7
# Rings:  4
# Heavy Atoms:  17

MedChem Properties

QED Drug-Likeness Score:  0.125
Synthetic Accessibility Score:  5.332
Fsp3:  0.425
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.004
MDCK Permeability:  4.91174723720178e-05
Pgp-inhibitor:  0.005
Pgp-substrate:  0.019
Human Intestinal Absorption (HIA):  0.009
20% Bioavailability (F20%):  0.035
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.015
Plasma Protein Binding (PPB):  99.96797943115234%
Volume Distribution (VD):  0.493
Pgp-substrate:  1.8472015857696533%

ADMET: Metabolism

CYP1A2-inhibitor:  0.881
CYP1A2-substrate:  0.02
CYP2C19-inhibitor:  0.883
CYP2C19-substrate:  0.04
CYP2C9-inhibitor:  0.961
CYP2C9-substrate:  0.978
CYP2D6-inhibitor:  0.96
CYP2D6-substrate:  0.101
CYP3A4-inhibitor:  0.438
CYP3A4-substrate:  0.057

ADMET: Excretion

Clearance (CL):  10.558
Half-life (T1/2):  0.924

ADMET: Toxicity

hERG Blockers:  0.004
Human Hepatotoxicity (H-HT):  0.327
Drug-inuced Liver Injury (DILI):  0.968
AMES Toxicity:  0.009
Rat Oral Acute Toxicity:  0.018
Maximum Recommended Daily Dose:  0.989
Skin Sensitization:  0.814
Carcinogencity:  0.896
Eye Corrosion:  0.003
Eye Irritation:  0.117
Respiratory Toxicity:  0.018

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC221352

Natural Product ID:  NPC221352
Common Name*:   Menisporopsin A
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  MZOGTSLLZCHVTJ-ACLVMWMJSA-N
Standard InCHI:  InChI=1S/C40H46O17/c1-18-6-23-11-27(42)15-30(45)35(23)38(50)55-20(3)8-26(41)13-25-14-29(44)17-32(47)37(25)40(52)57-22(5)10-34(49)54-19(2)7-24-12-28(43)16-31(46)36(24)39(51)56-21(4)9-33(48)53-18/h11-12,14-22,26,41-47H,6-10,13H2,1-5H3/t18-,19-,20-,21-,22-,26-/m1/s1
SMILES:  C[C@@H]1Cc2cc(cc(c2C(=O)O[C@H](C)C[C@H](Cc2cc(cc(c2C(=O)O[C@H](C)CC(=O)O[C@H](C)Cc2cc(cc(c2C(=O)O[C@H](C)CC(=O)O1)O)O)O)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL450847
PubChem CID:   5276743
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0002279] Benzene and substituted derivatives
        • [CHEMONTID:0000176] Benzoic acids and derivatives
          • [CHEMONTID:0001248] Hydroxybenzoic acid derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO3171 Menisporopsis theobromae Species n.a. Eukaryota n.a. n.a. n.a. PMID[15104506]
NPO3171 Menisporopsis theobromae Species n.a. Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens IC50 = 6.0 ug.mL-1 PMID[486201]
NPT485 Organism Plasmodium falciparum (isolate K1 / Thailand) Plasmodium falciparum K1 IC50 = 4.0 ug.mL-1 PMID[486201]
NPT88 Organism Mycobacterium tuberculosis Mycobacterium tuberculosis MIC = 50.0 ug.mL-1 PMID[486201]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 5.0 ug.mL-1 PMID[486201]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC221352 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9586 High Similarity NPC475460
0.9384 High Similarity NPC476684
0.9291 High Similarity NPC94248
0.9291 High Similarity NPC212693
0.9231 High Similarity NPC53649
0.922 High Similarity NPC70380
0.9189 High Similarity NPC309979
0.9189 High Similarity NPC307780
0.9161 High Similarity NPC155205
0.9155 High Similarity NPC191835
0.9155 High Similarity NPC472602
0.9097 High Similarity NPC472604
0.9097 High Similarity NPC158634
0.9097 High Similarity NPC472605
0.9091 High Similarity NPC32360
0.9091 High Similarity NPC139634
0.9091 High Similarity NPC105456
0.9085 High Similarity NPC71256
0.9048 High Similarity NPC473023
0.9028 High Similarity NPC472600
0.9028 High Similarity NPC158472
0.9028 High Similarity NPC472601
0.9021 High Similarity NPC478200
0.9021 High Similarity NPC33144
0.9014 High Similarity NPC235115
0.8986 High Similarity NPC12305
0.8973 High Similarity NPC471731
0.8973 High Similarity NPC478202
0.8973 High Similarity NPC159721
0.8973 High Similarity NPC469542
0.8973 High Similarity NPC51106
0.8966 High Similarity NPC1704
0.8966 High Similarity NPC478217
0.8966 High Similarity NPC472603
0.8966 High Similarity NPC313123
0.8966 High Similarity NPC67650
0.8958 High Similarity NPC268052
0.8954 High Similarity NPC257309
0.8951 High Similarity NPC194579
0.8951 High Similarity NPC301915
0.8951 High Similarity NPC261292
0.8936 High Similarity NPC153783
0.8919 High Similarity NPC237208
0.8912 High Similarity NPC42540
0.8912 High Similarity NPC151607
0.8904 High Similarity NPC250755
0.8904 High Similarity NPC469579
0.8904 High Similarity NPC471733
0.8904 High Similarity NPC474385
0.8889 High Similarity NPC475974
0.8851 High Similarity NPC83272
0.8851 High Similarity NPC134621
0.8851 High Similarity NPC29577
0.8844 High Similarity NPC472006
0.8844 High Similarity NPC472610
0.8836 High Similarity NPC478201
0.8836 High Similarity NPC244923
0.8836 High Similarity NPC472035
0.8828 High Similarity NPC88269
0.8819 High Similarity NPC178467
0.8819 High Similarity NPC149372
0.8819 High Similarity NPC65837
0.8819 High Similarity NPC474771
0.8819 High Similarity NPC474849
0.8811 High Similarity NPC142027
0.8808 High Similarity NPC60413
0.8794 High Similarity NPC189823
0.8794 High Similarity NPC219892
0.8792 High Similarity NPC470570
0.8784 High Similarity NPC210425
0.8784 High Similarity NPC66404
0.8784 High Similarity NPC277426
0.8784 High Similarity NPC86373
0.8784 High Similarity NPC280404
0.8784 High Similarity NPC95123
0.8767 High Similarity NPC275903
0.8766 High Similarity NPC146211
0.875 High Similarity NPC215921
0.875 High Similarity NPC70016
0.8742 High Similarity NPC237440
0.8742 High Similarity NPC270160
0.8742 High Similarity NPC6923
0.8741 High Similarity NPC175943
0.8734 High Similarity NPC7752
0.8733 High Similarity NPC476463
0.8733 High Similarity NPC81835
0.8733 High Similarity NPC125801
0.8733 High Similarity NPC471734
0.8732 High Similarity NPC476389
0.8725 High Similarity NPC257558
0.8725 High Similarity NPC34482
0.8718 High Similarity NPC472055
0.8707 High Similarity NPC475730
0.8699 High Similarity NPC112789
0.8699 High Similarity NPC247409
0.8699 High Similarity NPC19622
0.8699 High Similarity NPC474655
0.8693 High Similarity NPC273483
0.8693 High Similarity NPC167903
0.8693 High Similarity NPC478224
0.869 High Similarity NPC135837
0.8684 High Similarity NPC469670
0.8684 High Similarity NPC469619
0.8684 High Similarity NPC56204
0.8681 High Similarity NPC27407
0.8675 High Similarity NPC106328
0.8675 High Similarity NPC240253
0.8675 High Similarity NPC35150
0.8675 High Similarity NPC471642
0.8675 High Similarity NPC240622
0.8675 High Similarity NPC471641
0.8667 High Similarity NPC267509
0.8667 High Similarity NPC471735
0.8667 High Similarity NPC163846
0.8667 High Similarity NPC107625
0.8667 High Similarity NPC225173
0.8658 High Similarity NPC210966
0.8658 High Similarity NPC48762
0.8658 High Similarity NPC478203
0.8658 High Similarity NPC126882
0.8654 High Similarity NPC470339
0.8649 High Similarity NPC105648
0.8649 High Similarity NPC474961
0.8649 High Similarity NPC82913
0.8639 High Similarity NPC168471
0.863 High Similarity NPC9121
0.863 High Similarity NPC472403
0.863 High Similarity NPC177307
0.8627 High Similarity NPC240768
0.8627 High Similarity NPC478148
0.8627 High Similarity NPC91809
0.8627 High Similarity NPC470569
0.8627 High Similarity NPC200773
0.8627 High Similarity NPC133856
0.8625 High Similarity NPC249977
0.8621 High Similarity NPC50455
0.8621 High Similarity NPC291454
0.8621 High Similarity NPC158481
0.8618 High Similarity NPC4423
0.8618 High Similarity NPC291049
0.8618 High Similarity NPC77325
0.8618 High Similarity NPC233267
0.8609 High Similarity NPC210320
0.8609 High Similarity NPC472036
0.86 High Similarity NPC472034
0.86 High Similarity NPC32470
0.8592 High Similarity NPC247477
0.8592 High Similarity NPC17840
0.8591 High Similarity NPC310340
0.8581 High Similarity NPC69043
0.8581 High Similarity NPC89625
0.8581 High Similarity NPC220106
0.8581 High Similarity NPC37530
0.8581 High Similarity NPC478230
0.8581 High Similarity NPC149618
0.8571 High Similarity NPC275356
0.8571 High Similarity NPC474843
0.8571 High Similarity NPC52358
0.8571 High Similarity NPC43345
0.8571 High Similarity NPC92655
0.8562 High Similarity NPC164762
0.8562 High Similarity NPC470568
0.8562 High Similarity NPC477835
0.8562 High Similarity NPC472891
0.8562 High Similarity NPC205766
0.8553 High Similarity NPC73411
0.8553 High Similarity NPC2569
0.8553 High Similarity NPC215711
0.8553 High Similarity NPC172329
0.8553 High Similarity NPC105415
0.8552 High Similarity NPC180905
0.8552 High Similarity NPC182496
0.8544 High Similarity NPC69868
0.8543 High Similarity NPC202112
0.8543 High Similarity NPC472033
0.8543 High Similarity NPC25844
0.8543 High Similarity NPC51513
0.8533 High Similarity NPC470932
0.8533 High Similarity NPC21599
0.8533 High Similarity NPC193703
0.8531 High Similarity NPC214702
0.8531 High Similarity NPC470831
0.8526 High Similarity NPC227062
0.8526 High Similarity NPC471787
0.8523 High Similarity NPC137649
0.8523 High Similarity NPC135524
0.8523 High Similarity NPC49108
0.8516 High Similarity NPC137301
0.8516 High Similarity NPC472799
0.8516 High Similarity NPC470102
0.8516 High Similarity NPC478231
0.8514 High Similarity NPC99441
0.8514 High Similarity NPC64664
0.8514 High Similarity NPC470986
0.8509 High Similarity NPC76647
0.8506 High Similarity NPC78835
0.8506 High Similarity NPC476553
0.8506 High Similarity NPC476552
0.8506 High Similarity NPC474417
0.8506 High Similarity NPC204561

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC221352 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8758 High Similarity NPD7819 Suspended
0.8571 High Similarity NPD970 Clinical (unspecified phase)
0.8462 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8375 Intermediate Similarity NPD6232 Discontinued
0.8333 Intermediate Similarity NPD7473 Discontinued
0.8313 Intermediate Similarity NPD6959 Discontinued
0.8291 Intermediate Similarity NPD7768 Phase 2
0.8269 Intermediate Similarity NPD7411 Suspended
0.8239 Intermediate Similarity NPD7075 Discontinued
0.8235 Intermediate Similarity NPD2532 Approved
0.8235 Intermediate Similarity NPD2533 Approved
0.8235 Intermediate Similarity NPD2534 Approved
0.8176 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.817 Intermediate Similarity NPD7390 Discontinued
0.816 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8133 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8133 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8121 Intermediate Similarity NPD1510 Phase 2
0.8121 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.8089 Intermediate Similarity NPD4380 Phase 2
0.8079 Intermediate Similarity NPD1549 Phase 2
0.805 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.805 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8049 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8049 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8049 Intermediate Similarity NPD6166 Phase 2
0.8012 Intermediate Similarity NPD5844 Phase 1
0.8012 Intermediate Similarity NPD3749 Approved
0.8 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD1934 Approved
0.7987 Intermediate Similarity NPD6801 Discontinued
0.7974 Intermediate Similarity NPD3750 Approved
0.7973 Intermediate Similarity NPD1240 Approved
0.7959 Intermediate Similarity NPD3764 Approved
0.7947 Intermediate Similarity NPD2796 Approved
0.7947 Intermediate Similarity NPD5405 Approved
0.7947 Intermediate Similarity NPD5404 Approved
0.7947 Intermediate Similarity NPD5406 Approved
0.7947 Intermediate Similarity NPD5408 Approved
0.7917 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7901 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7888 Intermediate Similarity NPD3817 Phase 2
0.7867 Intermediate Similarity NPD1607 Approved
0.7857 Intermediate Similarity NPD7472 Approved
0.7857 Intermediate Similarity NPD7074 Phase 3
0.7838 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7829 Intermediate Similarity NPD2935 Discontinued
0.7824 Intermediate Similarity NPD7808 Phase 3
0.7821 Intermediate Similarity NPD6799 Approved
0.78 Intermediate Similarity NPD230 Phase 1
0.7798 Intermediate Similarity NPD7054 Approved
0.7798 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7792 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7765 Intermediate Similarity NPD7251 Discontinued
0.775 Intermediate Similarity NPD6599 Discontinued
0.7746 Intermediate Similarity NPD8150 Discontinued
0.7738 Intermediate Similarity NPD3818 Discontinued
0.7716 Intermediate Similarity NPD2801 Approved
0.7712 Intermediate Similarity NPD1551 Phase 2
0.7707 Intermediate Similarity NPD1511 Approved
0.7706 Intermediate Similarity NPD6797 Phase 2
0.7688 Intermediate Similarity NPD3226 Approved
0.7674 Intermediate Similarity NPD8312 Approved
0.7674 Intermediate Similarity NPD8313 Approved
0.7673 Intermediate Similarity NPD5403 Approved
0.7669 Intermediate Similarity NPD5402 Approved
0.7661 Intermediate Similarity NPD6559 Discontinued
0.7658 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD37 Approved
0.7651 Intermediate Similarity NPD7199 Phase 2
0.7647 Intermediate Similarity NPD3748 Approved
0.7628 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7628 Intermediate Similarity NPD4628 Phase 3
0.7622 Intermediate Similarity NPD3882 Suspended
0.7622 Intermediate Similarity NPD4966 Approved
0.7622 Intermediate Similarity NPD4967 Phase 2
0.7622 Intermediate Similarity NPD8151 Discontinued
0.7622 Intermediate Similarity NPD4965 Approved
0.7616 Intermediate Similarity NPD943 Approved
0.7616 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.761 Intermediate Similarity NPD1512 Approved
0.7607 Intermediate Similarity NPD1465 Phase 2
0.7605 Intermediate Similarity NPD5710 Approved
0.7605 Intermediate Similarity NPD5711 Approved
0.7586 Intermediate Similarity NPD1201 Approved
0.758 Intermediate Similarity NPD6190 Approved
0.7578 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7557 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7552 Intermediate Similarity NPD9545 Approved
0.7547 Intermediate Similarity NPD5401 Approved
0.753 Intermediate Similarity NPD6234 Discontinued
0.7516 Intermediate Similarity NPD6651 Approved
0.7516 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1470 Approved
0.75 Intermediate Similarity NPD7229 Phase 3
0.7484 Intermediate Similarity NPD6100 Approved
0.7484 Intermediate Similarity NPD6099 Approved
0.7467 Intermediate Similarity NPD6832 Phase 2
0.7456 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7438 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7427 Intermediate Similarity NPD7228 Approved
0.7419 Intermediate Similarity NPD7033 Discontinued
0.7413 Intermediate Similarity NPD9493 Approved
0.7403 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7399 Intermediate Similarity NPD5953 Discontinued
0.7381 Intermediate Similarity NPD5494 Approved
0.7375 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7351 Intermediate Similarity NPD4908 Phase 1
0.7342 Intermediate Similarity NPD1243 Approved
0.7342 Intermediate Similarity NPD2800 Approved
0.7325 Intermediate Similarity NPD2346 Discontinued
0.7312 Intermediate Similarity NPD8320 Phase 1
0.7312 Intermediate Similarity NPD8319 Approved
0.7308 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD2799 Discontinued
0.7296 Intermediate Similarity NPD7003 Approved
0.7289 Intermediate Similarity NPD8455 Phase 2
0.7284 Intermediate Similarity NPD6273 Approved
0.7283 Intermediate Similarity NPD7286 Phase 2
0.7268 Intermediate Similarity NPD7699 Phase 2
0.7268 Intermediate Similarity NPD7700 Phase 2
0.7267 Intermediate Similarity NPD1164 Approved
0.7267 Intermediate Similarity NPD1203 Approved
0.7263 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7263 Intermediate Similarity NPD7783 Phase 2
0.7258 Intermediate Similarity NPD7435 Discontinued
0.7255 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7247 Intermediate Similarity NPD8434 Phase 2
0.7239 Intermediate Similarity NPD920 Approved
0.7219 Intermediate Similarity NPD7870 Phase 2
0.7219 Intermediate Similarity NPD7871 Phase 2
0.7216 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD2344 Approved
0.7208 Intermediate Similarity NPD6663 Approved
0.7205 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7198 Intermediate Similarity NPD6535 Approved
0.7198 Intermediate Similarity NPD6534 Approved
0.7191 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD8166 Discontinued
0.7181 Intermediate Similarity NPD1608 Approved
0.7171 Intermediate Similarity NPD5736 Approved
0.7166 Intermediate Similarity NPD7698 Approved
0.7166 Intermediate Similarity NPD7696 Phase 3
0.7166 Intermediate Similarity NPD7697 Approved
0.7159 Intermediate Similarity NPD7240 Approved
0.7152 Intermediate Similarity NPD2797 Approved
0.7152 Intermediate Similarity NPD7458 Discontinued
0.7151 Intermediate Similarity NPD3926 Phase 2
0.7143 Intermediate Similarity NPD4288 Approved
0.7143 Intermediate Similarity NPD6973 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD3268 Approved
0.7143 Intermediate Similarity NPD6798 Discontinued
0.7126 Intermediate Similarity NPD7177 Discontinued
0.7126 Intermediate Similarity NPD3751 Discontinued
0.712 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD7874 Approved
0.7118 Intermediate Similarity NPD919 Approved
0.7117 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD7266 Discontinued
0.7105 Intermediate Similarity NPD2798 Approved
0.7097 Intermediate Similarity NPD6776 Approved
0.7097 Intermediate Similarity NPD6777 Approved
0.7097 Intermediate Similarity NPD6782 Approved
0.7097 Intermediate Similarity NPD6781 Approved
0.7097 Intermediate Similarity NPD6780 Approved
0.7097 Intermediate Similarity NPD6778 Approved
0.7097 Intermediate Similarity NPD6779 Approved
0.7093 Intermediate Similarity NPD3787 Discontinued
0.7072 Intermediate Similarity NPD4287 Approved
0.7067 Intermediate Similarity NPD9717 Approved
0.7067 Intermediate Similarity NPD9269 Phase 2
0.7066 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7062 Intermediate Similarity NPD7685 Pre-registration
0.7037 Intermediate Similarity NPD2309 Approved
0.7032 Intermediate Similarity NPD2313 Discontinued
0.7027 Intermediate Similarity NPD9268 Approved
0.7016 Intermediate Similarity NPD7701 Phase 2
0.7006 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD5124 Phase 1
0.7006 Intermediate Similarity NPD6355 Discontinued
0.7005 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD1610 Phase 2
0.7 Intermediate Similarity NPD422 Phase 1
0.6981 Remote Similarity NPD4308 Phase 3
0.698 Remote Similarity NPD17 Approved
0.6977 Remote Similarity NPD6746 Phase 2
0.6974 Remote Similarity NPD1283 Approved
0.6968 Remote Similarity NPD3027 Phase 3
0.6968 Remote Similarity NPD4625 Phase 3
0.6959 Remote Similarity NPD6971 Discontinued
0.6957 Remote Similarity NPD6213 Phase 3
0.6957 Remote Similarity NPD6212 Phase 3
0.6957 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6943 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6943 Remote Similarity NPD4060 Phase 1
0.6943 Remote Similarity NPD1613 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data